These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
116 related articles for article (PubMed ID: 11518645)
1. In vivo evaluation of 4-[123I]iodo-N-[2[4-(6-trifluoromethyl-2-pyridinyl)-1-piperazinyl]ethyl]benzamide, a potential SPECT radioligand for the 5-HT1A receptor. Vandecapelle M; De Vos F; Vermeirsch H; De Ley G; Audenaert K; Leysen D; Dierckx RA; Slegers G Nucl Med Biol; 2001 Aug; 28(6):639-43. PubMed ID: 11518645 [TBL] [Abstract][Full Text] [Related]
2. In vivo binding of [123I]4-(2'-methoxyphenyl)-1-[2'-(N-2"-pyridinyl)- p-iodobenzamido-]ethyl-piperazine, p-MPPI, to 5-HT1A receptors in rat brain. Kung MP; Zhuang ZP; Frederick D; Kung HF Synapse; 1994 Dec; 18(4):359-66. PubMed ID: 7886629 [TBL] [Abstract][Full Text] [Related]
3. 5-Hydroxytryptamine(1A) receptor-stimulated [(35)S]GTPgammaS binding in rat brain: absence of regional differences in coupling efficiency. Meller E; Li H; Carr KD; Hiller JM J Pharmacol Exp Ther; 2000 Feb; 292(2):684-91. PubMed ID: 10640306 [TBL] [Abstract][Full Text] [Related]
4. Inactivation of 5-HT(1A) receptors in hippocampal and cortical homogenates. Alper RH; Nelson DL Eur J Pharmacol; 2000 Feb; 390(1-2):67-73. PubMed ID: 10708708 [TBL] [Abstract][Full Text] [Related]
5. Characterization of 4-(2-hydroxyphenyl)-1-[2'-[N-(2''-pyridinyl)-p-fluorobenzamido]ethyl]piperazine (p-DMPPF) as a new potent 5-HT1A antagonist. Defraiteur C; Plenevaux A; Scuvée-Moreau J; Rouchet N; Goblet D; Luxen A; Seutin V Br J Pharmacol; 2007 Nov; 152(6):952-8. PubMed ID: 17704821 [TBL] [Abstract][Full Text] [Related]
6. Pharmacological characterization of in vivo properties of putative mixed 5-HT1A agonist/5-HT(2A/2C) antagonist anxiolytics. II. Drug discrimination and behavioral observation studies in rats. Kleven MS; Assié MB; Koek W J Pharmacol Exp Ther; 1997 Aug; 282(2):747-59. PubMed ID: 9262338 [TBL] [Abstract][Full Text] [Related]
7. The selective 5-HT1A antagonist radioligand [3H]WAY 100635 labels both G-protein-coupled and free 5-HT1A receptors in rat brain membranes. Gozlan H; Thibault S; Laporte AM; Lima L; Hamon M Eur J Pharmacol; 1995 Jan; 288(2):173-86. PubMed ID: 7720779 [TBL] [Abstract][Full Text] [Related]
8. Estimation of apparent pA2 values for WAY 100635 at 5-HT1A receptors regulating 5-hydroxytryptamine release in anaesthetised rats. Assié MB; Koek W Eur J Pharmacol; 2000 Dec; 409(2):173-7. PubMed ID: 11104831 [TBL] [Abstract][Full Text] [Related]
9. Effects of WAY 100635 and (-)-5-Me-8-OH-DPAT, a novel 5-HT1A receptor antagonist, on 8-OH-DPAT responses. Trillat AC; Malagié I; Mathé-Allainmat M; Anmela MC; Jacquot C; Langlois M; Gardier AM Eur J Pharmacol; 1998 Apr; 347(1):41-9. PubMed ID: 9650846 [TBL] [Abstract][Full Text] [Related]
10. The effect of serotonin(1A) receptor agonism on antipsychotic drug-induced dopamine release in rat striatum and nucleus accumbens. Ichikawa J; Meltzer HY Brain Res; 2000 Mar; 858(2):252-63. PubMed ID: 10708676 [TBL] [Abstract][Full Text] [Related]
11. Genomic responses to 5-HT1A or 5-HT2A/2C receptor activation is differentially regulated in four regions of rat brain. Tilakaratne N; Friedman E Eur J Pharmacol; 1996 Jun; 307(2):211-7. PubMed ID: 8832223 [TBL] [Abstract][Full Text] [Related]
12. Labelling of recombinant human and native rat serotonin 5-HT1A receptors by a novel, selective radioligand, [3H]-S 15535: definition of its binding profile using agonists, antagonists and inverse agonists. Newman-Tancredi A; Verrièle L; Chaput C; Millan MJ Naunyn Schmiedebergs Arch Pharmacol; 1998 Mar; 357(3):205-17. PubMed ID: 9550290 [TBL] [Abstract][Full Text] [Related]
13. Two selective 5-HT1A receptor antagonists, WAY-100 635 and NDL-249, stimulate locomotion in rats acclimatised to their environment and alter their behaviour: a behavioural analysis. Jackson DM; Wallsten CE; Jerning E; Hu PS; Deveney AM Psychopharmacology (Berl); 1998 Oct; 139(4):300-10. PubMed ID: 9809851 [TBL] [Abstract][Full Text] [Related]
14. Serotonin 1A receptor agonists reverse respiratory abnormalities in spinal cord-injured rats. Teng YD; Bingaman M; Taveira-DaSilva AM; Pace PP; Gillis RA; Wrathall JR J Neurosci; 2003 May; 23(10):4182-9. PubMed ID: 12764106 [TBL] [Abstract][Full Text] [Related]
15. 8-OH-DPAT influences extracellular levels of serotonin and dopamine in the medial preoptic area of male rats. Lorrain DS; Matuszewich L; Hull EM Brain Res; 1998 Apr; 790(1-2):217-23. PubMed ID: 9593901 [TBL] [Abstract][Full Text] [Related]
16. Tissue distribution, autoradiography, and metabolism of 4-(2'-methoxyphenyl)-1-[2' -[N-2"-pyridinyl)-p-[(18)F]fluorobenzamido]ethyl]piperazine (p-[(18)F]MPPF), a new serotonin 5-HT(1A) antagonist for positron emission tomography: An In vivo study in rats. Plenevaux A; Weissmann D; Aerts J; Lemaire C; Brihaye C; Degueldre C; Le Bars D; Comar D; Pujol J; Luxen A J Neurochem; 2000 Aug; 75(2):803-11. PubMed ID: 10899958 [TBL] [Abstract][Full Text] [Related]
17. The putative 5-HT1A receptor antagonist DU125530 blocks the discriminative stimulus of the 5-HT1A receptor agonist flesinoxan in pigeons. Mos J; Van Hest A; Van Drimmelen M; Herremans AH; Olivier B Eur J Pharmacol; 1997 May; 325(2-3):145-53. PubMed ID: 9163561 [TBL] [Abstract][Full Text] [Related]
18. In the formalin model of tonic nociceptive pain, 8-OH-DPAT produces 5-HT1A receptor-mediated, behaviorally specific analgesia. Bardin L; Tarayre JP; Koek W; Colpaert FC Eur J Pharmacol; 2001 Jun; 421(2):109-14. PubMed ID: 11399266 [TBL] [Abstract][Full Text] [Related]
19. Evaluation of [O-methyl-3H]WAY-100635 as an in vivo radioligand for 5-HT1A receptors in rat brain. Hume SP; Ashworth S; Opacka-Juffry J; Ahier RG; Lammertsma AA; Pike VW; Cliffe IA; Fletcher A; White AC Eur J Pharmacol; 1994 Dec; 271(2-3):515-23. PubMed ID: 7705452 [TBL] [Abstract][Full Text] [Related]
20. Synthesis and in vitro and in vivo functional studies of ortho-substituted phenylpiperazine and N-substituted 4-N-(o-methoxyphenyl)aminopiperidine analogues of WAY100635. Mensonides-Harsema MM; Liao Y; Böttcher H; Bartoszyk GD; Greiner HE; Harting J; de Boer P; Wikström HV J Med Chem; 2000 Feb; 43(3):432-9. PubMed ID: 10669570 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]